Imbio

Imbio Announces $1.5 Million Financing

Imbio, LLC, a medical imaging software company, has closed on $1.5 million in Series A financing. Existing investor Invenshure, LLC, led the round with additional funding from several angel investors. The proceeds will support the commercialization of Imbio’s proprietary Parametric Response Mapping (PRM) technology used to detect, characterize and quantify abnormal tissue in computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) images.

Imbio and NTT Data Services Announce Partnership for Lung Analytic Algorithms in the UCA Imaging Platform

November 28, 2016 – CHICAGO–(BUSINESS WIRE)–NTT DATA Services, formerly Dell Services, today announced its partnership with Imbio, which will provide algorithms for lung analytics. The algorithms are designed to further enhance automated tools for assisting radiology in identifying and quantifying disease present in existing and new imaging studies. The algorithms from Imbio provide for fully-automated quantification and visualization of lung structure, which is key to personalized diagnosis, surgical planning and therapy response monitoring. The Unified Clinical Archive (UCA) services from NTT DATA Services include a universal imaging analytics solution that supports machine vision and neural networks to more rapidly identify the extent of disease and accelerate the identification of incidental findings for early detection of potential chronic disease.

Imbio and GE Healthcare Collaborate to Enable Lung Density Analysis Within GE Health Cloud Ecosystem

MINNEAPOLIS, March 21, 2016 /PRNewswire/ — Imbio, a leader in fully automated, biomarker-based solutions for quantitative Lung imaging, and GE Healthcare are pleased to announce a collaboration to make Imbio’s Lung Density Analysis™, a volumetric imaging solution for Lung CT, one of the first software applications to be available in the GE Health Cloud.